🔎 Trials Near Me

Utama › Mieloma Pelbagai › Pennsylvania › Philadelphia

Kajian klinikal Mieloma Pelbagai di Philadelphia, PA

16 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Philadelphia (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Mengambil pesertaFasa 1
  • University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05652335

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 3
  • Thomas Jefferson University Hospital, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07258511

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Mengambil pesertaFasa 4
  • University of Pennsylvania, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05201781

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 1/2
  • Penn Medicine, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07116616

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Mengambil pesertaFasa 2
  • Fox Chase Cancer Center, Philadelphia
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02693535

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Mengambil pesertaFasa 2
  • Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06297226

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

Mengambil pesertaFasa 1/2
  • Research Site, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT06106945

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Mengambil pesertaFasa 3
  • Thomas Jefferson University Hospital, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT04566328

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Mengambil pesertaFasa 1
  • University of Pennsylvania, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05651932

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Mengambil pesertaFasa 1/2
  • Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jun 2026 · NCT04068597

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

Mengambil peserta
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Jun 2026 · NCT03858205

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Mengambil pesertaFasa 3
  • Abramson Cancer Center University of Pennsylvania Medical Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Jun 2026 · NCT05243797

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Mengambil pesertaFasa 1/2
  • Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Umur 12 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT04988555

Mozobil for Autologous Hematopoietic Stem Cell Transplantation

Mengambil pesertaFasa 2
  • Thomas Jefferson University Hospital, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Nov 2025 · NCT07188090

Limited-duration Teclistamab

Mengambil pesertaFasa 2
  • Abramson Cancer Center at University of Pennsylvania, Philadelphia
  • Thomas Jefferson University, Honickman Center, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2025 · NCT05932680

Kajian Mieloma Pelbagai di bandar lain

Kajian lain di Philadelphia

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.